Alarm bells as diabetes, Hepatitis C drugs fly off shelves
Medicines that treat the Hepatitis C (sofosbuvir) and diabetes (teneligliptin) emerged as the highest-selling drugs in 2016 among the new launches in the domestic retail market, a grim reminder of the alarming spread of lifestyle diseases in India.

The medicines and combinations for Hepatitis C, a liver infection, had the highest sales among the top 10 brands launched over a two-year period, with Natco Pharma’s Hepcinat (sofosbuvir) netting sales of Rs 158 crore, followed closely by Sun Pharma’s Revital H, a health supplement, with Rs 148 crore, data culled from market research firm AIOCD Awacs shows....